174 related articles for article (PubMed ID: 25520290)
1. In Vitro Modeling of Alcohol-Induced Liver Injury Using Human-Induced Pluripotent Stem Cells.
Tian L; Prasad N; Jang YY
Methods Mol Biol; 2016; 1353():271-83. PubMed ID: 25520290
[TBL] [Abstract][Full Text] [Related]
2. Alcohol Increases Liver Progenitor Populations and Induces Disease Phenotypes in Human IPSC-Derived Mature Stage Hepatic Cells.
Tian L; Deshmukh A; Prasad N; Jang YY
Int J Biol Sci; 2016; 12(9):1052-62. PubMed ID: 27570479
[TBL] [Abstract][Full Text] [Related]
3. Multisystemic Disease Modeling of Liver-Derived Protein Folding Disorders Using Induced Pluripotent Stem Cells (iPSCs).
Leung A; Murphy GJ
Methods Mol Biol; 2016; 1353():261-70. PubMed ID: 25646614
[TBL] [Abstract][Full Text] [Related]
4. Patient-Specific Induced Pluripotent Stem Cell Models: Generation and Characterization of Cardiac Cells.
Zanella F; Sheikh F
Methods Mol Biol; 2016; 1353():147-62. PubMed ID: 25520292
[TBL] [Abstract][Full Text] [Related]
5. Generation and Characterization of Patient-Specific iPSC Model for Cardiovascular Disease.
Lee YK; Ran X; Lai KW; Lau VY; Siu DC; Tse HF
Methods Mol Biol; 2016; 1353():191-213. PubMed ID: 26126449
[TBL] [Abstract][Full Text] [Related]
6. Transgene-Free Disease-Specific iPSC Generation from Fibroblasts and Peripheral Blood Mononuclear Cells.
Fidan K; Ebrahimi A; Çağlayan ÖH; Özçimen B; Önder TT
Methods Mol Biol; 2016; 1353():215-31. PubMed ID: 26126451
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes Under Defined Conditions.
van den Berg CW; Elliott DA; Braam SR; Mummery CL; Davis RP
Methods Mol Biol; 2016; 1353():163-80. PubMed ID: 25626427
[TBL] [Abstract][Full Text] [Related]
8. Defining optimal enzyme and matrix combination for replating of human induced pluripotent stem cell-derived cardiomyocytes at different levels of maturity.
Koc A; Sahoglu Goktas S; Akgul Caglar T; Cagavi E
Exp Cell Res; 2021 Jun; 403(2):112599. PubMed ID: 33848551
[TBL] [Abstract][Full Text] [Related]
9. An in vitro expansion system for generation of human iPS cell-derived hepatic progenitor-like cells exhibiting a bipotent differentiation potential.
Yanagida A; Ito K; Chikada H; Nakauchi H; Kamiya A
PLoS One; 2013; 8(7):e67541. PubMed ID: 23935837
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Caspase-8 does not protect from alcohol-induced liver apoptosis but alleviates alcoholic hepatic steatosis in mice.
Hao F; Cubero FJ; Ramadori P; Liao L; Haas U; Lambertz D; Sonntag R; Bangen JM; Gassler N; Hoss M; Streetz KL; Reissing J; Zimmermann HW; Trautwein C; Liedtke C; Nevzorova YA
Cell Death Dis; 2017 Oct; 8(10):e3152. PubMed ID: 29072704
[TBL] [Abstract][Full Text] [Related]
11. Modeling Axonal Phenotypes with Human Pluripotent Stem Cells.
Denton KR; Xu CC; Li XJ
Methods Mol Biol; 2016; 1353():309-21. PubMed ID: 25520289
[TBL] [Abstract][Full Text] [Related]
12. Generation of Cardiomyocytes from Pluripotent Stem Cells.
Nakahama H; Di Pasquale E
Methods Mol Biol; 2016; 1353():181-90. PubMed ID: 25523811
[TBL] [Abstract][Full Text] [Related]
13. An Efficient Method for the Differentiation of Human iPSC-Derived Endoderm toward Enterocytes and Hepatocytes.
Qiu S; Li Y; Imakura Y; Mima S; Hashita T; Iwao T; Matsunaga T
Cells; 2021 Apr; 10(4):. PubMed ID: 33917333
[TBL] [Abstract][Full Text] [Related]
14. Liver biopsy derived induced pluripotent stem cells provide unlimited supply for the generation of hepatocyte-like cells.
Calabrese D; Roma G; Bergling S; Carbone W; Mele V; Nuciforo S; Fofana I; Campana B; Szkolnicka D; Hay DC; Tchorz J; Bouwmeester T; Wieland S; Heim MH
PLoS One; 2019; 14(8):e0221762. PubMed ID: 31465481
[TBL] [Abstract][Full Text] [Related]
15. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ
J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272
[TBL] [Abstract][Full Text] [Related]
16. Donor-Dependent and Other Nondefined Factors Have Greater Influence on the Hepatic Phenotype Than the Starting Cell Type in Induced Pluripotent Stem Cell Derived Hepatocyte-Like Cells.
Heslop JA; Kia R; Pridgeon CS; Sison-Young RL; Liloglou T; Elmasry M; Fenwick SW; Mills JS; Kitteringham NR; Goldring CE; Park BK
Stem Cells Transl Med; 2017 May; 6(5):1321-1331. PubMed ID: 28456008
[TBL] [Abstract][Full Text] [Related]
17. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of hepatocytes from pluripotent stem cells.
Mallanna SK; Duncan SA
Curr Protoc Stem Cell Biol; 2013 Sep; 26():1G.4.1-1G.4.13. PubMed ID: 24510789
[TBL] [Abstract][Full Text] [Related]
19. Efficient and Controlled Generation of 2D and 3D Bile Duct Tissue from Human Pluripotent Stem Cell-Derived Spheroids.
Tian L; Deshmukh A; Ye Z; Jang YY
Stem Cell Rev Rep; 2016 Aug; 12(4):500-8. PubMed ID: 27138846
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte-derived macrophage migration inhibitory factor mediates alcohol-induced liver injury in mice and patients.
Marin V; Poulsen K; Odena G; McMullen MR; Altamirano J; Sancho-Bru P; Tiribelli C; Caballeria J; Rosso N; Bataller R; Nagy LE
J Hepatol; 2017 Nov; 67(5):1018-1025. PubMed ID: 28647568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
